Skip to main content

Arterial Occlusion clinical trials at University of California Health

2 in progress, 1 open to eligible people

Showing trials for
  • Comparing Perclose to Statseal in Conjunction With Perclose in Femoral 6 French Arteriotomy Closure

    open to eligible people ages 18 years and up

    The purpose of this clinical study is to compare how well two different devices for achieving hemostasis perform in patients undergoing transfemoral procedures with 6 French Access. Both devices are approved by the FDA for this use, and have already been used by clinicians on patients undergoing transfemoral procedures. It is believed that the use of both devices in combination compared to the Perclose alone will shorten the time that it takes to 'seal' the artery, resulting in a shorter period of time that patients would need to lay flat.

    at UCLA

  • PROMISE II: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia

    Sorry, in progress, not accepting new patients

    The LimFlow System is intended for endovascular, minimally invasive procedures in patients who have a clinical diagnosis of chronic limb-threatening ischemia and who have been determined to have no surgical or endovascular treatment option (i.e., "no option").

    at UCLA UCSF

Our lead scientists for Arterial Occlusion research studies include .

Last updated: